NCT00409851View on ClinicalTrials.gov

One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

1,293

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Hypertension
Interventions
DRUG

valsartan+amlodipine

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Sites in Germany

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00409851 - One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension | Biotech Hunter | Biotech Hunter